قارن الطرق

	أهداف: مقياس الحركة اللاإرادية الشاذة (AIMS)	مقياس هنت وهيس	MDS-UPDRS	مقياس المعاهد الوطنية للصحة للسكتة الدماغية (NIHSS)
المجال	طب الأعصاب	طب الأعصاب	طب الأعصاب	طب الأعصاب
العائلة	Process / pipeline	Process / pipeline	Process / pipeline	Process / pipeline
سنة النشأة	1976	1968	2008	1989
صاحب الطريقة	National Institute of Mental Health	William E. Hunt and Robert M. Hess	Christopher G. Goetz and Movement Disorder Society	Thomas Brott and NIH Stroke Study Group
النوع	Clinician-rated observation	Clinician-rated	Clinician-rated	Clinician-rated
المصدر التأسيسي	National Institute of Mental Health (1976). Abnormal Involuntary Movement Scale (AIMS). In: Rockland, L. H., Schooler, N. R., & Levine, J. (Eds.), Drug Treatment of Mental Disorders. New York: Raven Press.	Hunt, W. E., Hess, R. M. (1968). Surgical risk as related to time of intervention in the repair of intracranial aneurysms. Journal of Neurosurgery, 28(1), 14-20.	Goetz, C. G., et al. (2008). Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): Scale presentation and clinimetric testing results. Movement Disorders, 23(15), 2129-2170.	Brott, T., Adams, H. P., Olinger, C. P., et al. (1989). Measurements of acute cerebral infarction: A clinical examination scale. Stroke, 20(7), 864-870.
الأسماء البديلة	AIMS	Hunt-Hess Grade	UPDRS	NIH Stroke Scale
ذات صلة	3	4	5	5
الملخص	The Abnormal Involuntary Movement Scale (AIMS) is the standard clinical rating scale for assessing tardive dyskinesia, a iatrogenic movement disorder resulting from chronic antipsychotic medication exposure. Developed by the National Institute of Mental Health in 1976, the 12-item scale systematically measures involuntary movements across facial, oral, limb, and trunk regions. The AIMS is mandatory screening tool for patients on long-term antipsychotic therapy and essential for monitoring antipsychotic-associated movement complications.	The Hunt and Hess Scale is the most widely used clinical grading system for assessing severity and prognosis in subarachnoid hemorrhage (SAH) caused by ruptured intracranial aneurysm. Developed by neurosurgeons William Hunt and Robert Hess in 1968, the five-point ordinal scale measures level of consciousness and presence of focal neurological deficits. Hunt-Hess grade at admission is the single strongest predictor of 30-day mortality and functional outcome and guides urgency of neurosurgical intervention.	The MDS-UPDRS is the gold-standard clinician-administered rating scale for assessing motor and non-motor manifestations of Parkinson's disease. Developed by the Movement Disorder Society in 2008 to enhance the original UPDRS, it measures disease severity across daily living, motor function, and treatment complications. Used globally in clinical trials, longitudinal cohort studies, and routine neurological practice.	The NIHSS is the standard acute stroke severity assessment tool used in emergency departments, stroke centers, and clinical trials worldwide. Developed by the NIH Stroke Study Group in 1989, the 15-item scale provides rapid, reproducible quantification of acute neurological deficit from ischemic or hemorrhagic stroke. NIHSS scores inform thrombolytic and thrombectomy eligibility, predict outcomes, and serve as primary endpoint in stroke intervention trials.